Chief Attending, Radiochemistry & Imaging Sciences Service

Exciting Opportunity At Msk: Chief Attending, Radiochemistry & Imaging Sciences Service

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe.

Spearhead the development of innovative radiochemistry research initiatives aimed at the clinical translation of scientific discoveries into patient care. Collaborate closely with the Chief of the Molecular Imaging and Therapy Service (MITS) and the Radiochemistry and Molecular Imaging Probe (RMIP) Core to align radiochemistry efforts with clinical operations and translational research priorities. Lead a multidisciplinary team advancing translational radiochemistry and radiopharmaceutical science, overseeing their own laboratory and coordinating research activities across the Service. Provide scientific and strategic vision for the design, synthesis, evaluation and clinical translation of novel radiotracers and radiopharmaceuticals for diagnostic and therapeutic applications. Foster a collaborative, interdisciplinary environment by mentoring faculty, trainees and technical staff and promoting excellence in radiochemistry research and development.

Key Requirements

• Nationally and internationally recognized scientific leader with a proven record of innovation in the development, validation, and clinical translation of diagnostic and theranostic probes for molecular imaging and therapy.
• Experience with core facility operations including cyclotron production, radiolabeling, regulatory compliance and the ability to strategically integrate these capabilities into research and clinical translation.
• Demonstrated success in building collaborative teams and partnerships across clinical, research, and translational domains.
• Excellent organizational, leadership, and communication skills, with the ability to articulate vision, set priorities, and advance institutional research and clinical goals.

Core Skills

• PhD in Radiochemistry (or closely related discipline) with deep expertise in radiochemistry, molecular probe design, and radiopharmaceutical development for imaging and therapy.
• Strong record of peer-reviewed publications and research funding.
• Experience with technology transfer, intellectual property, or industry collaborations preferred.
• Commitment to mentorship, education, and faculty development.

Application Instructions

Submit C.V., letter of interest, and references in your application submission to: Contact Name: Valentina Salkow Contact Email: salkowv@mskcc.org

Pay Range: $300,000 - $440,000

Additional Details About The Positions

Today, the Service combines state-of-the-art cyclotron production and radiolabeling with research in tumor-targeting probes, multi-modality imaging (PET, MRI, optical) and targeted radionuclide therapies to deliver precision cancer diagnosis and therapy. The Service houses eleven independent research labs- each with their own individual research portfolios. Each year, the Service's work results in novel first-in human trials.